<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210331050801N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-12</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of Ibuprofen and Piroxicam on pain relief after surgery</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of  the prophylactic effectiveness of intravenous Ibuprofen and intramuscular Piroxicam on pain intensity after lower abdominal surgery under general anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57225</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, block randomization method is used. Patients who have the inclusion criteria are selected sequentially so that the first 3 are considered as a block and Then, using random allocation software, they are randomly divided into 3 groups: ibuprofen, piroxicam and control. This process continues until 90 patients enter the study. Thus, we will have equally 30 patients in each group (ibuprofen, piroxicam and control), Blinding description: Participants in study are unaware of the type of drug being injected. An anesthesiologist, who has no role in data collecting, prepares the medication in same volume and injects them. The data collector and the person who evaluating the outcome are not aware of the grouping of patients and the type of injected drug But the data analyzer is informed.</study_design>
      <phase>3</phase>
      <hc_freetext>Postoperative pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Immediately after induction of anesthesia (which is the same in all 3 groups) and before surgical incision, 20 mg Piroxicam (made by Alborz daroo factory) is injected intramuscularly into patient who is going to have lower abdominal surgery. Intervention 2: Intervention group: Immediately after induction of anesthesia (which is the same in all 3 groups) and before surgical incision, 400 mg Ibuprofen (made by Caspian factory) is injected intravenously into patient who is going to have lower abdominal surgery. Intervention 3: Control group: Immediately after induction of anesthesia (which is the same in all 3 groups) and before surgical incision, Normal saline serum (With a volume equal to the other two group`s drug) is injected intravenously into patient who is going to have lower abdominal surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all of data is potentially shareable after unidentifying individuals.

When:
Access period starts 6 months after the results are published.

To whom:
Researchers working in academic and scientific institutions

Conditions:
use in other studies

Where to obtain:
khalili@med.mui.ac.ir

How to obtain:
After sending email, the request is read and reviewed and then will be answered as soon as possible.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Gholamreza Khalili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Al-Zahra hospital, Sofe Blvd.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3620 1992</telephone>
        <email>khalili@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Gholamreza Khalili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Al-Zahra hospital, Sofe Blvd.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3620 1992</telephone>
        <email>khalili@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>ASA1 and ASA2 patient
Patient aged 25 to 65 years
Patients undergoing lower abdominal surgery
No history of drugs, alcohol and benzodiazepine addiction
No history of seizures, psychiatric problems, liver and kidney disease, gastrointestinal bleeding, peptic ulcer and Coagulation disorder
No allergy to the drugs used in the study</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.18</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other acute postprocedural pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Immediately after induction of anesthesia (which is the same in all 3 groups) and before surgical incision, 20 mg Piroxicam (made by Alborz daroo factory) is injected intramuscularly into patient who is going to have lower abdominal surgery.</i_keyword>
      <i_keyword>Intervention group: Immediately after induction of anesthesia (which is the same in all 3 groups) and before surgical incision, 400 mg Ibuprofen (made by Caspian factory) is injected intravenously into patient who is going to have lower abdominal surgery.</i_keyword>
      <i_keyword>Control group: Immediately after induction of anesthesia (which is the same in all 3 groups) and before surgical incision, Normal saline serum (With a volume equal to the other two group`s drug) is injected intravenously into patient who is going to have lower abdominal surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intensity of postoperative pain. Timepoint: Immediately after consciousness in recovery and 2, 8, 12 and 24 hours after surgery. Method of measurement: visual analogue scale.</prim_outcome>
      <prim_outcome>The amount of opioid used in the first 24 hours after surgery. Timepoint: First 24 hours after surgery. Method of measurement: Reading the patient file.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: At the beginning of surgery and then every 30 minutes during surgery. Method of measurement: Digital barometer.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: At the beginning of surgery and then every 30 minutes during surgery. Method of measurement: Pulse oximeter.</prim_outcome>
      <prim_outcome>Duration of stay in recovery. Timepoint: After leaving the recovery. Method of measurement: Minute.</prim_outcome>
      <prim_outcome>Extubation time. Timepoint: After extubation. Method of measurement: Minute.</prim_outcome>
      <prim_outcome>The first time of requesting opioid after surgery. Timepoint: After end of surgery. Method of measurement: Minute.</prim_outcome>
      <prim_outcome>Degree of patients' satisfaction with pain relief. Timepoint: 24 hours after surgery. Method of measurement: Use of visual analogue scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Isfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-07-11</approval_date>
        <contact_name>Ethics committee of Isfahan university of medical sciences</contact_name>
        <contact_address>Hezar jarib Ave, Azadi Square Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
